Courant Investment Management LLC decreased its holdings in Monsanto (NYSE:MON) by 44.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,396 shares of the basic materials company’s stock after selling 40,200 shares during the period. Monsanto accounts for about 4.1% of Courant Investment Management LLC’s holdings, making the stock its 11th biggest position. Courant Investment Management LLC’s holdings in Monsanto were worth $5,885,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Meyer Handelman Co. increased its stake in shares of Monsanto by 0.6% in the third quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after purchasing an additional 706 shares in the last quarter. Toronto Dominion Bank increased its stake in shares of Monsanto by 6.3% in the third quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after purchasing an additional 59,750 shares in the last quarter. Amalgamated Bank increased its stake in shares of Monsanto by 2.0% in the third quarter. Amalgamated Bank now owns 52,909 shares of the basic materials company’s stock worth $6,340,000 after purchasing an additional 1,022 shares in the last quarter. Oakbrook Investments LLC grew its stake in Monsanto by 7.4% during the third quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock valued at $2,438,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Janus Henderson Group PLC grew its stake in Monsanto by 57.1% during the third quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock valued at $280,696,000 after acquiring an additional 851,369 shares in the last quarter. Hedge funds and other institutional investors own 75.37% of the company’s stock.
Monsanto (NYSE MON) traded down $0.91 during mid-day trading on Thursday, reaching $118.81. 3,494,500 shares of the company’s stock were exchanged, compared to its average volume of 3,693,373. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. Monsanto has a fifty-two week low of $106.97 and a fifty-two week high of $122.79. The stock has a market cap of $52,300.00, a PE ratio of 21.96, a PEG ratio of 1.71 and a beta of 1.04.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a yield of 1.82%. Monsanto’s dividend payout ratio is presently 39.93%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.79% of the stock is owned by insiders.
MON has been the subject of several recent analyst reports. Wells Fargo & Co boosted their price objective on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Barclays reaffirmed an “equal weight” rating and set a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Finally, Macquarie cut shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $127.30.
TRADEMARK VIOLATION WARNING: “Courant Investment Management LLC Sells 40,200 Shares of Monsanto (MON)” was published by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://baseballnewssource.com/markets/courant-investment-management-llc-sells-40200-shares-of-monsanto-mon/1845263.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.